Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE0005664809
Thu, 08.08.2024
Evotec SE
Key scientific achievement advances the joint neuroscience pipeline and earns a payment of US$ 25 m to Evotec to progress further research
Hamburg, Germany, 08 August 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced progress within the Company’s strategic partnership wit [ … ]
Wed, 07.08.2024
Evotec SE
Hamburg, Germany, 07 August 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for the first half-year of 2024 on Wednesday, 14 August 2024.
The Company is going to hold a conference call to discuss the results as well as provide an update on its performance. The con [ … ]
Tue, 06.08.2024
Evotec SE
Navigating through a challenging H1 2024: Unsatisfying revenue dynamics in Shared R&D; Just – Evotec Biologics with mid double-digit revenue growth versus strong comparable basis
Adjusted EBITDA impacted by high fixed cost base in Shared R&D and ramp-up costs for J.POD Toulouse, France
Further strengthened sales order book i [ … ]
Wed, 10.07.2024
Evotec SE
Multi-year collaboration will initially focus on early discovery research for metabolic and infectious diseases
Hamburg, Germany, 10 July 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced it has entered into a multi-year master research collaboration and option and licens [ … ]
Mon, 08.07.2024
Evotec SE
Just – Evotec Biologics expands partnership with Sandoz for development and commercial manufacturing of biosimilars
Additional biosimilars potentially to be added to Sandoz development pipeline
Further guarantees for Sandoz long-term commercial supply security
Hamburg, Germany, and Seattle, WA, USA, 8 July 2024:
Evotec SE [ … ]
Tue, 25.06.2024
Evotec SE
Just – Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD’s Manufacturing Optimization Program
Manufacturing solution includes seamless integration of accelerated mAb drug development into the overall Manufacturing Optimization Program
Manufacturing Optimization P [ … ]
Wed, 12.06.2024
Evotec SE
Key scientific achievement advances the joint pipeline in the strategic neuroscience partnership with Bristol Myers Squibb and earns a payment of US$ 20 m to Evotec to progress further research
Hamburg, Germany, 12 June 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today th [ … ]
Mon, 10.06.2024
Evotec SE
Most agenda items adopted with great majority
Annual General Meeting 2024 elects Dr Duncan McHale and Wesley Wheeler to the Supervisory Board, replacing Dr Elaine Sullivan and Dr Mario Polywka
Hamburg, Germany, 10 June 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced [ … ]
Thu, 30.05.2024
Evotec SE
Partnership will expand Evotec’s molecular patient database in the area of metabolic diseases and in particular obesity
Evotec will leverage its leading PanOmics technologies for the generation of large omics data sets including transcriptomics, proteomics and metabolomics
Lille University Hospital will provide human biological samp [ … ]
Thu, 30.05.2024
Evotec SE
Partnership will expand Evotec’s molecular patient database in the area of metabolic diseases and in particular obesity
Evotec will leverage its leading PanOmics technologies for the generation of large omics data sets including transcriptomics, proteomics and metabolomics
Lille University Hospital will provide human biological samp [ … ]